 |
|
| Blog results | Results 1 - 10 of about 1,092 for gemcitabine and capecitabine. (0.21 seconds) |
| Sorted by relevance Sort by date |
| 27 Oct 2009 According to research published early online in the Journal of Clinical Oncology, gemcitabine in combination with capecitabine (GEM-CAP) should be considered as one of the standard first-line options in locally advanced and metastatic ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ [ More results from NeLM - News ] |
| 5 Nov 2009 by Dr. NICK BACKGROUND: No previous prospective trials have been reported with capecitabine and gemcitabine (CAP-GEM) in patients with metastatic thymic epithelial tumors (TETs). We conducted a multicenter study to determine the activity and ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ [ More results from CANCER AND IMPORTANT MEDICAL NEWS ] |
| 12 Nov 2009 RATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride, capecitabine, and fluorouracil, work in different ways to stop the growth of tumor cel... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 11 Nov 2009 by Alice Rossiter As has been the pattern for these studies, patients saw little or no benefit from the experimental treatment, in this case, a combination of gemcitabine and capecitabine, as compared with gemcitabine alone. ... Cancer Drug News Editor's Blog - http://cancerdrugnewsblog.blogspot.com/ [ More results from Cancer Drug News Editor's Blog ] |
| 22 hours ago by ML Scheithauer W, Schüll B, Ulrich-Pur H, et al, Gemcitabine alone or in combination with capecitabine in patients with advanced pancreatic adenocarcinoma. Proceedings of the American Society of Clinical Oncology;21:126a, abstract number ... Cancer Treatment - http://cancertreatments.typepad.com/cancer_treatment/ [ More results from Cancer Treatment ] |
| 23 Sep 2009 Among these clinical trials are three ongoing randomized Phase II studies, including a trial to evaluate Nexavar plus paclitaxel in the first-line setting, a trial to evaluate Nexavar plus gemcitabine or capecitabine in the first- or ... PharmaNews.eu - http://www.pharmanews.eu/component/content/frontpage [ More results from PharmaNews.eu ] |
| 28 Aug 2009 by Crane, Winter, Regine, Safran, Rich, Curran,... Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411 ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ - References [ More results from Journal of Clinical Oncology Current Issue ] |
| 23 Feb 2007 by Santini, D, Virzi, V, Vincenzi, B, Rocci,... Background: Capecitabine and gemcitabine given as fixed dose rate (FDR) has not been demonstrated to be well tolerated in phase I previous studies. The goals of this phase I study were to determine the maximum-tolerated dose of this ... Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/ [ More results from Annals of Oncology - recent issues ] |
| 4 Oct 2009 One of two remaining trials is evaluating Nexavar plus gemcitabine or capecitabine in the first- or second-line setting following progression on bevacizumab, and the second trial is evaluating Nexavar plus docetaxel and/or letrozole in ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html - References [ More results from Drugs.com - Clinical Trials ] |
| 9 Nov 2009 by admin Single-drug program is the most widely used taxane drug; Since 2002, a number of clinical studies confirm that taxane based on the joint use of certain chemotherapy drugs (such as capecitabine, gemcitabine and so on) may be further ... Breast Cancer Information Site - http://breastcancer123.org/ [ More results from Breast Cancer Information Site ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
